stella
beta
Clinical Study Evaluating the Safety and Efficacy of Esomeprazole in Treatment of Non-alcoholic Steatohepatitis — Stella
Recruiting
Back to Fatty Liver Disease trials
Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.
Trial locations
(1 site)
Egypt
National Liver Institute, Shibīn al Kawm
View full record on ClinicalTrials.gov